Biothreat & Pathogen Detection

Advanced Technologies for Detection, Diagnostics and Analytics

June 28, 2022 ALL TIMES EDT

The COVID-19 pandemic has exposed everyone to what the lack of funded preparedness results in. As emerging pathogens increasingly jump from animals to humans, the number of outbreaks grow and it is critical to learn from the mistakes of this pandemic and prepare for the next coming threats. The 29th International Biodetection Technologies: Biothreat and Pathogen Detection is an internationally recognized meeting for experts in detection & identification of biological threats. This conference will address the key topics in pathogen detection and present the latest R&D and technological innovation in ready-to-market systems. In addition, this meeting will focus on the latest strategies to overcoming the hurdles to the identification of global biological threats and translational gaps in bringing technologies from lab to field. This conference will feature stimulating discussions, perspectives of end users, high quality case studies and provides the opportunity to network with the leading experts in detection from around the globe. This event is in conjunction with our 29th International Biodetection Technologies: Point-Of-Care Diagnostics for Global Health and Biodefense, and together, these events will provide two full days of programming in both the field and the lab.

Tuesday, June 28

8:55 am

Organizer's Opening Remarks

Craig Wohlers, Executive Director, Conferences, Cambridge Healthtech Institute

ADVANCED METHODS FOR BIODETECTION

8:57 am

Chairperson's Remarks

Willy Valdivia-Granda, Founder & CEO, Orion Integrated Biosciences, Inc.
9:00 am

UltraSEQ: Flexible Bioinformatic Software for Accurate, Science-Informed Detection of Biological Threats from Genomic Datasets

Bryan Gemler, Lead Biological Data Scientist, Battelle

For users who need simplistic, high-confidence, actionable information from genomic data, Battelle’s UltraSEQ software provides a cloud-deployed flexible system architecture, high-quality data, and algorithms for pathogen and biothreat identification. UltraSEQ’s base functionality takes input genomic data and efficiently outputs prediction results for taxonomy, biothreat function, and a user-defined rules engine backed by Battelle's curated Sequence of Concern Database. Applications in sample analysis, biosurveillance, and diagnostics will be presented.

9:30 am

xBIRD: An Automated, Near-Real-Time, Low Size, Weight, and Power (SWaP) Biological Agent Identification Device Using Extreme PCR

Bryan Rivers, Biologist, DEVCOM Chemical Biological Center

We have leveraged innovations in sensor miniaturization and rapid thermocycling to develop xBIRD, a fully integrated and automated biothreat agent detection system. The device draws in an aerosolized sample, performs sample extraction and lysis, amplifies target nucleic acids, and generates a result in under 5 minutes. Current work is underway to adapt the device to a form factor which can adapt to multiple operational scenarios.

10:00 am

Testing the Tests: Assessing the Impact of Mutations in SARS-CoV-2 Variants on Molecular Diagnostics Tests

Shanmuga Sozhamannan, PhD, Technical Coordinator, Joint Project Lead, Defense Biological Product Assurance Office (DBPAO), CBRND Enabling Biotechnologies (JPL CBRND EB)

Diagnostic assays are crucial tools to test, diagnose and treat infectious and other diseases. They continue to remain extremely valuable in the current COVID-19 pandemics not only to provide appropriate health care for infected and symptomatic individuals as needed but also for implementing public health measures such as test, trace and isolate infected and asymptomatic individuals to prevent further transmission of the virus. Sustained transmission and unhindered proliferation of the pathogen across the population during a continuous, ongoing pandemic such as COVID-19, has resulted in many variants with mutations. These mutations may lead to signature erosion, a phenomenon wherein diagnostic tests developed using the genetic sequence of the original pathogen may fail and cause false-negative results in a sample containing a new variant. We have developed a tool called PSET (PCR Signature Erosion Tool) to monitor the performance of diagnostic tests in silico using the genome sequences of pathogens. We will present and discuss our data on Ebola, Lassa, and SARS-CoV-2 in demonstrating the power of real-time in silico monitoring on identifying diagnostics failures, thereby driving rapid modification of assays if signature erosion is evident.

10:30 am Session Break
11:00 am

Nanopore Sequencing for Biothreat Detection and Characterization

Cory Bernhards, PhD, Research Biologist, DEVCOM Chemical Biological Center

Nanopore sequencing technology has enabled numerous applications for rapidly identifying and characterizing biological threats. Warfighters are being trained to execute these protocols, which will revolutionize biothreat detection in the field. Methods for sample/library preparation are being further simplified/automated for use by non-laboratory trained operators, and bioinformatics software was designed to automatically identify biothreats in real-time. In addition, protocols have been used to monitor for SARS-CoV-2 variants among warfighter populations.

11:30 am

Challenges and Parameters in Collecting Airborne COVID-19

Dave Alburty, CEO, InnovaPrep

Air sampling for SARS-CoV-2 within the built environment has been challenging due to the interaction of many factors. Sampling strategies must account for aerosol emission rates from infectious individuals, environmental factors including controls and mitigation efforts, collection techniques, and identification methods. An overall synopsis of these factors and an approach to determining a sampling and analysis strategy will be discussed.

12:00 pm

Multiplexed Real-Time Clot Digestion Analysis Leveraging a Fluorescently-Labeled Annular Fibrin Clot

Nathan Alves, PhD, Assistant Professor, Emergency Medicine, Indiana University

A fluorescently-labeled fibrin clot lysis assay utilizing a unique annular clot geometry will be discussed. Physiologically-relevant fibrin formulations, with microstructure that resembles in vivo, were validated achieving high assay sensitivity. Clot characteristics were examined using thromboelastography (TEG), turbidity, SEM, and confocal microscopy. Sample fibrinolytic activities at varying plasmin, plasminogen, and tissue plasminogen activator (tPA) concentrations were assessed to demonstrate assay capabilities for use in determining a subject’s fibrinolytic state.

John Lesnick, Director of Commercial Applications, Marketing, DNA Script

Oligo supply delays slow down the labs responsible for biothreat detection and monitoring, hindering rapid response. With the SYNTAX System, powered by Enzymatic DNA Synthesis from DNA Script, any lab can print DNA primers and probes on-demand multiple times per day, allowing labs to maintain security and control over the biothreat response. In this talk, we present data from qPCR, FISH, and NGS applications for viral detection and variant analysis.

1:00 pm Session Break

RAPID AND FUTURE TECHNOLOGIES FOR BIODETECTION

1:40 pm

Chairperson's Remarks

Cory Bernhards, PhD, Research Biologist, DEVCOM Chemical Biological Center
1:45 pm

Rapid and Automated Identification of Aerosolized Biothreats

Vishaka Santosh, PhD, Postdoctoral Fellow, DEVCOM Chemical Biological Center, Aberdeen Proving Ground

Available methods for biological aerosol collection and identification are slow and require manual intervention. In order to achieve rapid, automated, and unmanned identification of aerosolized biothreats, we have developed a portable low-cost prototype that couples a customized microwell aerosol collector with an automated elution module and conducts fully-automated sample preparation and loop-mediated isothermal amplification (LAMP) analysis for rapid and accurate biothreat identification.

2:15 pm

Adaptation and Development of a SARS-CoV-2 Aerosol Detection Instrument Platform Based upon the BioFlash Biological Identifier 

Andrew R. Flannery, PhD, Chief Scientist, Biotechnology, Smiths Detection

In light of the COVID pandemic, detecting airborne pathogens is more important than ever. For an aerosol diagnostic to be useful, it must be able to supply accurate results within minutes of detection, which in turn will facilitate the rapid deployment of the appropriate mitigations. During my presentation, I will detail how Smiths Detection, a global leader in threat detection, adapted its BioFlash instrument to be capable of detecting SARS-CoV-2.

2:45 pm

Design and Use of a Novel Substrate for Simple, Rapid, and Specific Early Detection of Anthrax Infection

Nancy Shine, PhD, CSO & Director R&D, R&D, List Biological Labs, Inc.

A fast, sensitive, specific, and accurate detection method to determine active infection by Bacillus anthracis in plasma has been developed. The inhalation form of Bacillus anthracis infection can rapidly lead to a serious blood infection.  There is a limited window of time for diagnosis and successful use of antibiotics.  The List method detects the presence of anthrax lethal factor (LF), which appears in the blood early in an infection. A fluorescently labeled peptide substrate, MAPKKide Plus, which is not cleaved by plasma proteases and thus is specific for LF, was identified and is adaptable to a point-of-care diagnostic.

IDENTIFICATION & MANAGEMENT OF EMERGING AND REEMERGING PATHOGENS

3:00 pm

Beyond Traditional Biodetection: A Metagenomics Pilot Study for Strategic Decision-Making

Lisa Foddrill, Director, CBRN Lab, Pentagon Force Protection Agency

Biodefense laboratories have relied on traditional molecular methods such as PCR and immunological assays for rapid detection of biological threats for over 20 years. While these methods are sensitive and provide critical early warning of biological threats, they are limited to detecting specific pathogens that can be present in the environment naturally. Characterizing the environmental background is important to interpreting results from these methods. Developing pathogen-agnostic methods is needed to detect emerging and advanced biological threats to address advances in biotechnology and the biothreat landscape. We developed and piloted a metagenomics method to characterize the environmental background of indoor and outdoor aerosol samples for spatial and temporal differences. Results from this characterization can provide additional information during a biothreat incident to ensure confidence in results and enhance decision-making and response.

3:45 pm Session Break & Interactive Discussions

Interactive Discussions are informal discussions, allowing participants to exchange ideas and experiences and develop future collaborations around a focused topic. Each discussion will be led by a facilitator who keeps the discussion on track and the group engaged. The format will be in an online networking platform. To get the most out of this format, please come prepared to share examples from your work, be a part of a collective, problem-solving session, and participate in active idea sharing. Please visit the Interactive Discussion page on the conference website for a complete listing of topics and descriptions.

TABLE 1: Automated Biological Identification

Vishaka Santosh, PhD, Postdoctoral Fellow, DEVCOM Chemical Biological Center, Aberdeen Proving Ground

TABLE 2: Using Single-Molecule Sequencing Methods for Routine Bio-Surveillance of Pathogens in Wastewater 

David Ussery, PhD, Director ArC GEM & Professor, Biomedical Informatics, University of Arkansas for Medical Sciences

TABLE 3: Rapid Biodetection Methods for Biopharma and Cellular Ag

Dave Alburty, CEO, InnovaPrep

TABLE 4: Early Warning and Forecast of Infectious Disease Outbreaks: Really or Fiction?

Willy Valdivia-Granda, Founder & CEO, Orion Integrated Biosciences, Inc.

TABLE 5: Agnostic Detection: Definition and Solution

Andrew R. Flannery, PhD, Chief Scientist, Biotechnology, Smiths Detection

TABLE 6: The Use of Metagenomics for Pathogen Detection – Advantages, Applications, and Technical Gaps

Bryan Gemler, Lead Biological Data Scientist, Battelle
4:20 pm

RIGEL: A Genomic-Based Enterprise for Unknown Pathogen Characterization

Willy Valdivia-Granda, Founder & CEO, Orion Integrated Biosciences, Inc.
4:50 pm

Feature Engineering for Optimizing Field-Forward Biosurveillance of Emergent Unknown RNA Viruses

Joseph Russell, PhD, Senior Scientist, Global Health Surveillance & Diagnostics, MRIGlobal

Building from our prior work developing a degenerate k-mer method to accommodate high intra-sequence variation of RNA virus genomes for modeling frameworks, and leveraging a taxonomic ‘group-shuffle-split’ paradigm on complete coronavirus assemblies from prior to October 2018, we trained multiple regularized logistic regression classifiers at the nucleotide k-mer level capable of accurately predicting withheld SARS-CoV-2 genome sequences as human pathogens and accurately predicting withheld Swine Acute Diarrhea Syndrome coronavirus (SADS-CoV) genome sequences as non-human pathogens. LASSO feature selection identified several degenerate nucleotide predictor motifs with high model coefficients for the human pathogen class that were present across widely disparate classes of coronaviruses. We discuss the utility of predictive models (and their associated predictor motifs) to novel biosurveillance protocols that substantially increase the ‘pound-for-pound’ information content of field-collected sequencing data and make a strong argument for the necessity of routine collection and sequencing of zoonotic viruses.

5:20 pm

Novel Tools for Detection of Emerging Zoonotic Pathogens

Neeraja Venkateswaran, PhD, Senior Scientist, R&D, Tetracore, Inc.

About 60% of known human pathogens are known to have originated from animals. The emergence and re-emergence of zoonotic infectious agents pose a considerable risk to global health. The increased frequency of international movement of the human and animal population can potentially lead to a rapid spread of the emerging zoonotic pathogens. Early detection is vital for developing a comprehensive approach to contain outbreaks of zoonotic pathogens. Here I will discuss sensitive detection tools and efficient sampling strategies for surveillance studies. 

5:50 pm Session Break
6:00 pm Recommended Short Course*

SC1: Rapid Sample Preparation for Pathogen Detection
*Separate registration required. See short course page for details.

7:30 pm Close of Biothreat & Pathogen Detection Conference





Register Early for Maximum Savings